Proteolix's Series A Round

Proteolix raised a round of funding on April 16, 2003.

Proteolix is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers by introducing proteasome inhibition and thereby disrupt…

Articles about Proteolix's Series A Round: